InsiderTrades

Form 4 for CRVS Corvus Pharmaceuticals, Inc.

Accepted 2026-05-20 16:12:25 ET · period of report 2026-05-18 · accession 0001610717-26-000160 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2026-05-20 16:12 2026-05-18 CRVS MILLER RICHARD A MD Pres, CEO, Dir P - Purchase $12.04 +6,932 1.20M +0.6% +$83.5K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-18 P A 5,000 $12.05 1,193,103 I By Trust — — (F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
2 Common Common Stock 2026-05-18 P A 1,932 $12.01 1,195,035 I By Trust — — (F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.